| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abiraterone increases survival in metastatic prostate cancer
|
Abraham, Jame
|
|
2012
|
|
8 |
p. 240-242
3 p.
|
artikel
|
| 2 |
Another step forward in RCC treatment
|
Knopf, Kevin B.
|
|
2007
|
|
8 |
p. 478-479
2 p.
|
artikel
|
| 3 |
An overview of adjuvant chemotherapy for resected non-small cell lung cancer: focus on the ECOG 1505 phase III trial
|
Socinski, Mark A.
|
|
2008
|
|
8 |
p. 457-463
7 p.
|
artikel
|
| 4 |
Approaches to applying breast cancer risk prediction models in clinical practice
|
Bellcross, Cecelia
|
|
2009
|
|
8 |
p. 373-379
7 p.
|
artikel
|
| 5 |
Apps for the iPad and other tablets
|
Fried, John J.
|
|
2011
|
|
8 |
p. 381-382
2 p.
|
artikel
|
| 6 |
ASCO beyond McCormick: perseverance, collaboration, and mentorship
|
Kim, Joseph W.
|
|
2012
|
|
8 |
p. 265-
1 p.
|
artikel
|
| 7 |
Bevacizumab added to chemotherapy increases PFS in ovarian, related cancers
|
OSTERWEIL, NEIL
|
|
2010
|
|
8 |
p. 380-381
2 p.
|
artikel
|
| 8 |
Binary dependent variables: logistic regression
|
Norman, Geoffrey R.
|
|
2010
|
|
8 |
p. 367-368
2 p.
|
artikel
|
| 9 |
Bosutinib induces high response rates in imatinib-resistant/intolerant CML patients
|
OSTERWEIL, NEIL
|
|
2010
|
|
8 |
p. 374-
1 p.
|
artikel
|
| 10 |
BRCA1/2 testing in patients with newly diagnosed breast cancer
|
Nusbaum, Rachel
|
|
2009
|
|
8 |
p. 367-371
5 p.
|
artikel
|
| 11 |
Can some ER-positive breast cancer patients forgo chemotherapy?
|
Young, Patrick
|
|
2006
|
|
8 |
p. 487-490
4 p.
|
artikel
|
| 12 |
Carboplatin-paclitaxel combo extends survival in NSCLC
|
DALES, MARY JO
|
|
2010
|
|
8 |
p. 377-378
2 p.
|
artikel
|
| 13 |
Chemoradiotherapy increases local control of invasive bladder cancer
|
OSTERWEIL, NEIL
|
|
2010
|
|
8 |
p. 372-373
2 p.
|
artikel
|
| 14 |
Choosing prostate cancer therapy with multimedia software
|
Young, Patrick
|
|
2010
|
|
8 |
p. 359-360
2 p.
|
artikel
|
| 15 |
CME in cyberspace
|
Fried, John J.
|
|
2006
|
|
8 |
p. 514-
1 p.
|
artikel
|
| 16 |
Concurrent chemoradiotherapy for the synchronous presentation of limited-stage small cell and early-stage non-small cell lung cancers
|
Watkins, John M.
|
|
2010
|
|
8 |
p. 362-365
4 p.
|
artikel
|
| 17 |
Congress hears testimony on Medicare concerns
|
Coplon, Steven M.
|
|
2006
|
|
8 |
p. 539-
1 p.
|
artikel
|
| 18 |
Data and cancer care: play or pay
|
Bosserman, Linda D.
|
|
2009
|
|
8 |
p. 336-
1 p.
|
artikel
|
| 19 |
Developing and implementing a survivorship program in a community cancer center
|
Kendall, Jeff
|
|
2007
|
|
8 |
p. 502-504
3 p.
|
artikel
|
| 20 |
Dispensing oral medications: why now and how?
|
Moseley, Warren G.
|
|
2009
|
|
8 |
p. 358-361
4 p.
|
artikel
|
| 21 |
Early palliative care boosts lung cancer survival
|
MACNEIL, JANE SALODOF
|
|
2010
|
|
8 |
p. 378-379
2 p.
|
artikel
|
| 22 |
First-bite syndrome: a novel complication of carotid body paraganglioma resection
|
Trenery, Alyssa
|
|
2011
|
|
8 |
p. 375-378
4 p.
|
artikel
|
| 23 |
First move the goal posts, and then change the team: an evaluation of the EORTC intergroup study 30987
|
Streiner, David L.
|
|
2012
|
|
8 |
p. 263-264
2 p.
|
artikel
|
| 24 |
Gemcitabine or capecitabine: does it matter which comes first in treating pancreatic cancer?
|
WENDLING, PATRICE
|
|
2010
|
|
8 |
p. 382-383
2 p.
|
artikel
|
| 25 |
Genetic approaches to sarcoma diagnosis
|
Bridge, Julia A.
|
|
2006
|
|
8 |
p. 525-528
4 p.
|
artikel
|
| 26 |
Highlights of ASCO: Selected reports from the 46th annual meeting of the American Society of Clinical Oncology
|
WENDLING, PATRICE
|
|
2010
|
|
8 |
p. 369-370
2 p.
|
artikel
|
| 27 |
Hormone and HER2 receptor status can change when breast tumors progress
|
WENDLING, PATRICE
|
|
2010
|
|
8 |
p. 371-372
2 p.
|
artikel
|
| 28 |
Imatinib: a study in the quality of adverse events reporting
|
Samaras, Athena T.
|
|
2009
|
|
8 |
p. 365-366
2 p.
|
artikel
|
| 29 |
Implementing evidence-based guidelines for preventing chemotherapy-induced neutropenia: from paper to clinical practice
|
Maxwell, Cathy
|
|
2006
|
|
8 |
p. 530-536
7 p.
|
artikel
|
| 30 |
Incidence and risk factors for chemotherapy-induced nausea or vomiting following highly or moderately emetogenic chemotherapy in community oncology practice
|
Feinberg, Bruce A.
|
|
2010
|
|
8 |
p. 347-354
8 p.
|
artikel
|
| 31 |
In-depth updates and reviews, and a plea for streamlining research paperwork
|
Bosserman, Linda D.
|
|
2008
|
|
8 |
p. 425-
1 p.
|
artikel
|
| 32 |
In the pipeline: IL-21 active in metastatic melanoma
|
WENDLING, PATRICE
|
|
2010
|
|
8 |
p. 379-380
2 p.
|
artikel
|
| 33 |
Ipilimumab emerges as first treatment to improve melanoma survival
|
MACNEIL, JANE SALODOF
|
|
2010
|
|
8 |
p. 379-
1 p.
|
artikel
|
| 34 |
Keeping it practical—and patient-focused
|
Bosserman, Linda D.
|
|
2006
|
|
8 |
p. 474-
1 p.
|
artikel
|
| 35 |
KRAS mutational analysis: pathology's perspective
|
Dixon, Lisa R.
|
|
2008
|
|
8 |
p. 436-
1 p.
|
artikel
|
| 36 |
KRAS mutational analysis: ready for prime time?
|
George Jr., Thomas J.
|
|
2008
|
|
8 |
p. 435-436
2 p.
|
artikel
|
| 37 |
KRAS status as a predictor of response to EGFR inhibitors in mCRC
|
Abraham, Jame
|
|
2008
|
|
8 |
p. 433-435
3 p.
|
artikel
|
| 38 |
Maintenance therapy in solid tumors
|
Smit, Marie-Anne
|
|
2012
|
|
8 |
p. 247-258
12 p.
|
artikel
|
| 39 |
Managing and avoiding bortezomib toxicity
|
Menashe, Jeffrey
|
|
2007
|
|
8 |
p. 480-484
5 p.
|
artikel
|
| 40 |
Managing drug accountability
|
Friedman, Lyssa
|
|
2007
|
|
8 |
p. 487-489
3 p.
|
artikel
|
| 41 |
Managing oral drugs: getting up to ‘MUSTER’
|
Bosserman, Linda D.
|
|
2010
|
|
8 |
p. 341-
1 p.
|
artikel
|
| 42 |
Mantle cell lymphoma: an overview of diagnostic and therapeutic advances
|
Harris, Thomas J.
|
|
2008
|
|
8 |
p. 465-472
8 p.
|
artikel
|
| 43 |
Mechanisms of action of commonly used drugs to treat cancer
|
Trigg, Michael E.
|
|
2011
|
|
8 |
p. 357-369
13 p.
|
artikel
|
| 44 |
Metastatic melanoma: an AJCC review
|
Agarwala, Sanjiv S.
|
|
2008
|
|
8 |
p. 441-445
5 p.
|
artikel
|
| 45 |
Multifocal bone infarctions in both knees: an unusual presentation of multiple myeloma
|
Hui, Ying-Kei
|
|
2011
|
|
8 |
p. 370-374
5 p.
|
artikel
|
| 46 |
Nasal septum perforation induced by bevacizumab therapy in patients with breast cancer
|
Chaudhary, Lubna
|
|
2012
|
|
8 |
p. 259-262
4 p.
|
artikel
|
| 47 |
Nearly half of patients survive 2 years with bevacizumab, temozolomide, and radiotherapy-based glioblastoma regimen
|
HYER, RICHARD
|
|
2010
|
|
8 |
p. 373-374
2 p.
|
artikel
|
| 48 |
Noninferiority trials
|
Streiner, David L.
|
|
2009
|
|
8 |
p. 380-382
3 p.
|
artikel
|
| 49 |
Novel agents for chronic myeloid leukemia: from imatinib to dasatinib and nilotinib: overcoming resistance
|
Deininger, Michael W.N.
|
|
2006
|
|
8 |
p. 519-523
5 p.
|
artikel
|
| 50 |
Nutrition and exercise in cancer survivors
|
Solti, Magdolna
|
|
2012
|
|
8 |
p. 266-268
3 p.
|
artikel
|
| 51 |
Offering our highest quality cancer care
|
Bosserman, Linda D.
|
|
2007
|
|
8 |
p. 470-
1 p.
|
artikel
|
| 52 |
Oncologists could face more Medicare cuts in debt deal
|
Schneider, Mary Ellen
|
|
2011
|
|
8 |
p. 383-384
2 p.
|
artikel
|
| 53 |
Oncologist shortage: is it an organizational problem?
|
Young, Patrick
|
|
2010
|
|
8 |
p. 384-
1 p.
|
artikel
|
| 54 |
Pancreatic cancer survival reaches new milestone with Folfirinox chemotherapy
|
WENDLING, PATRICE
|
|
2010
|
|
8 |
p. 381-382
2 p.
|
artikel
|
| 55 |
Paraneoplastic limbic encephalitis associated with small-cell lung cancer
|
Rosenfeld, Myrna R.
|
|
2007
|
|
8 |
p. 491-494
4 p.
|
artikel
|
| 56 |
PARP inhibitors in breast cancer
|
Abraham, Jame
|
|
2009
|
|
8 |
p. 341-342
2 p.
|
artikel
|
| 57 |
PARP inhibitors: making progress toward individualized treatment in breast cancer
|
Tan, Antoinette R.
|
|
2009
|
|
8 |
p. 342-343
2 p.
|
artikel
|
| 58 |
PCA3 permutation increases the prostate biopsy yield
|
Siegrist, Timothy C.
|
|
2012
|
|
8 |
p. 243-246
4 p.
|
artikel
|
| 59 |
Positron emission tomography in early detection of relapse in high-risk melanoma patients: a retrospective review
|
Kottschade, Lisa A.
|
|
2009
|
|
8 |
p. 344-347
4 p.
|
artikel
|
| 60 |
Promising data, but challenges remain in selecting appropriate TKIs
|
Mirshahidi, Hamid
|
|
2011
|
|
8 |
p. 355-356
2 p.
|
artikel
|
| 61 |
Radiation therapy helps cut locally advanced prostate cancer deaths by 43%
|
HYER, RICHARD
|
|
2010
|
|
8 |
p. 383-
1 p.
|
artikel
|
| 62 |
Savvy purchasing
|
Murray, Edward J.
|
|
2006
|
|
8 |
p. 501-502
2 p.
|
artikel
|
| 63 |
Senators Specter and Casey introduce Community Cancer Care Preservation Act
|
Coplon, Steven M.
|
|
2007
|
|
8 |
p. 513-
1 p.
|
artikel
|
| 64 |
Serum levels of HER2/neu, a potential alternative to tissue specimen levels in the management of metastatic breast cancer: a case report and literature review
|
Swayampakula, Anil Kumar
|
|
2009
|
|
8 |
p. 362-364
3 p.
|
artikel
|
| 65 |
Sipuleucel-T immunotherapy for advanced prostate cancer
|
Abraham, Jame
|
|
2010
|
|
8 |
p. 342-344
3 p.
|
artikel
|
| 66 |
Size, follow-up, data analysis—good; post hoc analysis, interpretation—not so much
|
Streiner, David L.
|
|
2011
|
|
8 |
p. 379-380
2 p.
|
artikel
|
| 67 |
Skipping axillary dissection safe when sentinel node is negative
|
LONDON, SUSAN
|
|
2010
|
|
8 |
p. 370-371
2 p.
|
artikel
|
| 68 |
Surgical management of colorectal liver metastases
|
Abdalla, Eddie K.
|
|
2009
|
|
8 |
p. 349-357
9 p.
|
artikel
|
| 69 |
Synchronous hilar cholangiocarcinoma and gallbladder cancer
|
Naik, Seema
|
|
2008
|
|
8 |
p. 447-451
5 p.
|
artikel
|
| 70 |
Temsirolimus for advanced renal cell carcinoma
|
Abraham, Jame
|
|
2007
|
|
8 |
p. 476-478
3 p.
|
artikel
|
| 71 |
The conundrum of sipuleucel-T for prostate cancer
|
Knopf, Kevin B.
|
|
2010
|
|
8 |
p. 343-344
2 p.
|
artikel
|
| 72 |
The evolving role of laparoscopy in the surgical management of oncology patients
|
Wernsing, David S.
|
|
2006
|
|
8 |
p. 507-511
5 p.
|
artikel
|
| 73 |
The FDA draws upon new authority to mandate elements of ESA labeling
|
Marson, Brian
|
|
2008
|
|
8 |
p. 455-456
2 p.
|
artikel
|
| 74 |
The old and the new
|
Schwartzberg, Lee S.
|
|
2011
|
|
8 |
p. 341-342
2 p.
|
artikel
|
| 75 |
The TAILORx trial: individualized options for treatment
|
Sparano, Joseph A.
|
|
2006
|
|
8 |
p. 494-496
3 p.
|
artikel
|
| 76 |
Understanding the estrogen receptor signaling pathway: focus on current endocrine agents for breast cancer in postmenopausal women
|
Brufsky, Adam M.
|
|
2011
|
|
8 |
p. 343-352
10 p.
|
artikel
|
| 77 |
Update on minimally invasive surgery in the management of gynecologic malignancies: focus on robotic laparoscopic systems
|
Tillmanns, Todd D.
|
|
2007
|
|
8 |
p. 505-511
7 p.
|
artikel
|
| 78 |
Vandetanib in advanced hereditary medullary thyroid cancer
|
Abraham, Jame
|
|
2011
|
|
8 |
p. 353-354
2 p.
|
artikel
|
| 79 |
What the ACA ruling means for community oncologists
|
Henry, David H.
|
|
2012
|
|
8 |
p. 237-
1 p.
|
artikel
|
| 80 |
Where does abiraterone fit into the metastatic prostate cancer treatment algorithm?
|
Armstrong, Andrew J.
|
|
2012
|
|
8 |
p. 238-239
2 p.
|
artikel
|
| 81 |
With cost pressures up, will nurses be targeted again?
|
Friese, Christopher R.
|
|
2006
|
|
8 |
p. 483-484
2 p.
|
artikel
|
Tijdschrift beschrijving